These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16534091)

  • 21. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
    Kocken M; Helmerhorst TJ; Berkhof J; Louwers JA; Nobbenhuis MA; Bais AG; Hogewoning CJ; Zaal A; Verheijen RH; Snijders PJ; Meijer CJ
    Lancet Oncol; 2011 May; 12(5):441-50. PubMed ID: 21530398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cancer prevention - a paradigm shift?
    Denny L; De Sousa M; Kuhn L; Pollack A; Wright TC
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S12. PubMed ID: 16450428
    [No Abstract]   [Full Text] [Related]  

  • 23. Status quo and prevention of overtreatment in cervical diseases.
    Tianmin X; Weiqin C; Manhua C; Yang L; Lihui S; Tianshu W; Xiaocui L
    Eur J Gynaecol Oncol; 2012; 33(3):300-3. PubMed ID: 22873104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
    Boardman LA; Kennedy CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of women with low-grade squamous intraepithelial lesions on cytologic evidence or biopsy results by board-certified gynecologists.
    Lee C; Mancuso V; Contant T; Jackson R; Smith-Mccune K
    Am J Obstet Gynecol; 2003 Mar; 188(3):693-8. PubMed ID: 12634642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Author's reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
    Vaccarella S; Clifford GM; Howell-Jones R; Snijders PJ; Franceschi S;
    Int J Cancer; 2011 Sep; 129(5):1283-5. PubMed ID: 21080437
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical question: ask the expert.
    Tseng AG; Dornfest F
    J Low Genit Tract Dis; 2009 Apr; 13(2):118-9. PubMed ID: 19387134
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of statistics in an advancement of cancer research.
    Lee JS
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S44-5. PubMed ID: 17727925
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of low-grade squamous intraepithelial lesions of the uterine cervix.
    Scheungraber C; Kleekamp N; Schneider A
    Br J Cancer; 2004 Mar; 90(5):975-8. PubMed ID: 14997192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of cervical precancers: a global perspective.
    Echelman D; Feldman S
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the cost-effective evaluation and management of atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesions.
    Horowitz IR
    Cancer; 1998 Feb; 84(1):1-4. PubMed ID: 9500645
    [No Abstract]   [Full Text] [Related]  

  • 32. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
    Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
    J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal pap smear and cervical cancer in pregnancy.
    Yang KY
    Clin Obstet Gynecol; 2012 Sep; 55(3):838-48. PubMed ID: 22828115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttreatment assessment of women at risk of developing high-grade cervical disease: proposal for new guidelines based on data from the Netherlands.
    Uijterwaal MH; Kocken M; Berkhof J; Bekkers RL; Verheijen RH; Helmerhorst TJ; Meijer CJ
    J Low Genit Tract Dis; 2014 Oct; 18(4):338-43. PubMed ID: 24769656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular interferon-beta treatment of cervical intraepithelial neoplasia II associated with human papillomavirus infection.
    De Aloysio D; Miliffi L; Iannicelli T; Penacchioni P; Bottiglioni F
    Acta Obstet Gynecol Scand; 1994 May; 73(5):420-4. PubMed ID: 8009976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice guidelines: cervical cancer. Society of Gynecologic Oncologists Medical Practice Ethics Committee.
    Oncology (Williston Park); 1998 Jan; 12(1):134-8. PubMed ID: 9474593
    [No Abstract]   [Full Text] [Related]  

  • 37. The proposed change to primary HPV screening in New Zealand: reasons for caution.
    Fitzgerald P; Cox B; Miller A; Hill S; Reid J
    N Z Med J; 2016 Mar; 129(1431):18-22. PubMed ID: 27005869
    [No Abstract]   [Full Text] [Related]  

  • 38. 2012 cervical cancer screening guidelines and the future role of HPV testing.
    Priebe AM
    Clin Obstet Gynecol; 2013 Mar; 56(1):44-50. PubMed ID: 23337843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2006 consensus guidelines for the management of women with abnormal cervical screening tests.
    Wright TC; Massad LS; Dunton CJ; Spitzer M; Wilkinson EJ; Solomon D;
    J Low Genit Tract Dis; 2007 Oct; 11(4):201-22. PubMed ID: 17917566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colposcopy.
    Smith T
    Nurs Stand; 1997 Jul; 11(45):49-54; quiz 55-6. PubMed ID: 9326013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.